• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用多种肿瘤标志物联合对恶性胸腔积液进行诊断:五种机器学习模型的比较研究。

Diagnosis of malignant pleural effusion with combinations of multiple tumor markers: A comparison study of five machine learning models.

机构信息

Department of Biostatistics, School of Public Health, Peking University, Beijing, China.

Department of Respiration and Critical Care Medicine, Beijing Chaoyang Hospital, Beijing, China.

出版信息

Int J Biol Markers. 2023 Jun;38(2):139-146. doi: 10.1177/03936155231158125. Epub 2023 Feb 27.

DOI:10.1177/03936155231158125
PMID:36847282
Abstract

BACKGROUND

To evaluate the diagnostic value of combinations of tumor markers carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 125, CA153, and CA19-9 in identifying malignant pleural effusion (MPE) from non-malignant pleural effusion (non-MPE) using machine learning, and compare the performance of popular machine learning methods.

METHODS

A total of 319 samples were collected from patients with pleural effusion in Beijing and Wuhan, China, from January 2018 to June 2020. Five machine learning methods including Logistic regression, extreme gradient boosting (XGBoost), Bayesian additive regression tree, random forest, and support vector machine were applied to evaluate the diagnostic performance. Sensitivity, specificity, Youden's index, and the area under the receiver operating characteristic curve (AUC) were used to evaluate the performance of different diagnostic models.

RESULTS

For diagnostic models with a single tumor marker, the model using CEA, constructed by XGBoost, performed best (AUC = 0.895, sensitivity = 0.80), and the model with CA153, also by XGBoost, showed the largest specificity 0.98. Among all combinations of tumor markers, the combination of CEA and CA153 achieved the best performance (AUC = 0.921, sensitivity = 0.85) in identifying MPE under the diagnostic model constructed by XGBoost.

CONCLUSIONS

Diagnostic models for MPE with a combination of multiple tumor markers outperformed the models with a single tumor marker, particularly in sensitivity. Using machine learning methods, especially XGBoost, could comprehensively improve the diagnostic accuracy of MPE.

摘要

背景

为了利用机器学习评估癌胚抗原(CEA)、糖类抗原(CA)125、CA153 和 CA19-9 等肿瘤标志物联合用于鉴别恶性胸腔积液(MPE)与非恶性胸腔积液(non-MPE)的诊断价值,并比较几种常用机器学习方法的性能。

方法

收集了 2018 年 1 月至 2020 年 6 月中国北京和武汉胸腔积液患者的 319 份样本。应用逻辑回归、极端梯度提升(XGBoost)、贝叶斯加法回归树、随机森林和支持向量机等 5 种机器学习方法来评估诊断性能。采用敏感度、特异度、约登指数和受试者工作特征曲线下面积(AUC)来评价不同诊断模型的性能。

结果

对于单个肿瘤标志物的诊断模型,XGBoost 构建的 CEA 模型表现最佳(AUC=0.895,敏感度=0.80),XGBoost 构建的 CA153 模型特异性最高(0.98)。在所有肿瘤标志物组合中,XGBoost 构建的 CEA 和 CA153 组合模型在鉴别 MPE 方面性能最佳(AUC=0.921,敏感度=0.85)。

结论

多肿瘤标志物联合诊断模型优于单个肿瘤标志物模型,尤其在敏感度方面。利用机器学习方法,特别是 XGBoost,可全面提高 MPE 的诊断准确性。

相似文献

1
Diagnosis of malignant pleural effusion with combinations of multiple tumor markers: A comparison study of five machine learning models.采用多种肿瘤标志物联合对恶性胸腔积液进行诊断:五种机器学习模型的比较研究。
Int J Biol Markers. 2023 Jun;38(2):139-146. doi: 10.1177/03936155231158125. Epub 2023 Feb 27.
2
Development and validation of a machine learning model for differential diagnosis of malignant pleural effusion using routine laboratory data.基于常规实验室数据的机器学习模型对恶性胸腔积液进行鉴别诊断的建立与验证。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231208632. doi: 10.1177/17534666231208632.
3
Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study.1,230 例患者中六种肿瘤标志物对恶性胸腔积液的诊断价值:一项单中心回顾性研究。
Pathol Oncol Res. 2022 Apr 20;28:1610280. doi: 10.3389/pore.2022.1610280. eCollection 2022.
4
[The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].[B7-H4与癌胚抗原在诊断良恶性胸腔积液中的价值]
Zhonghua Zhong Liu Za Zhi. 2017 Jul 23;39(7):524-527. doi: 10.3760/cma.j.issn.0253-3766.2017.07.009.
5
Use of tumor markers in distinguishing lung adenocarcinoma-associated malignant pleural effusion from tuberculous pleural effusion.肿瘤标志物在鉴别肺腺癌相关恶性胸腔积液与结核性胸腔积液中的应用。
Am J Med Sci. 2024 Aug;368(2):136-142. doi: 10.1016/j.amjms.2024.04.001. Epub 2024 Apr 5.
6
Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.肿瘤标志物对肺腺癌相关恶性胸腔积液的诊断价值:一项验证性研究和Meta分析
Int J Clin Oncol. 2017 Apr;22(2):283-290. doi: 10.1007/s10147-016-1073-y. Epub 2016 Dec 18.
7
The Diagnosis of Malignant Pleural Effusion Using Tumor-Marker Combinations: A Cost-Effectiveness Analysis Based on a Stacking Model.使用肿瘤标志物组合诊断恶性胸腔积液:基于堆叠模型的成本效益分析
Diagnostics (Basel). 2023 Oct 5;13(19):3136. doi: 10.3390/diagnostics13193136.
8
Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.SiSo细胞表达的可溶性受体结合癌抗原和癌胚抗原在鉴别恶性与良性胸腔积液中的诊断价值
Tumour Biol. 2016 Mar;37(3):3257-64. doi: 10.1007/s13277-015-4174-8. Epub 2015 Oct 5.
9
Diagnostic Accuracy of Combinations of Tumor Markers for Malignant Pleural Effusion: An Updated Meta-Analysis.肿瘤标志物联合检测对恶性胸腔积液的诊断准确性:一项更新的荟萃分析。
Respiration. 2017;94(1):62-69. doi: 10.1159/000468545. Epub 2017 Apr 21.
10
Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion.CTLA-4、癌胚抗原和细胞角蛋白19片段对恶性胸腔积液的诊断效能
Postgrad Med. 2017 Aug;129(6):644-648. doi: 10.1080/00325481.2017.1331112. Epub 2017 May 19.

引用本文的文献

1
Harnessing AI for Improved Detection and Classification of Pleural Effusion: Insights and Innovations.利用人工智能改进胸腔积液的检测与分类:见解与创新
Can Respir J. 2025 Aug 6;2025:2882255. doi: 10.1155/carj/2882255. eCollection 2025.
2
CA125 as a Potential Biomarker in Non-Malignant Serous Effusions: Diagnostic and Prognostic Considerations.CA125作为非恶性浆液性积液中的潜在生物标志物:诊断和预后考量
J Clin Med. 2025 Jun 11;14(12):4152. doi: 10.3390/jcm14124152.
3
Machine learning-based Diagnostic model for determining the etiology of pleural effusion using Age, ADA and LDH.
基于机器学习的诊断模型,用于利用年龄、腺苷脱氨酶(ADA)和乳酸脱氢酶(LDH)确定胸腔积液的病因
Respir Res. 2025 May 2;26(1):170. doi: 10.1186/s12931-025-03253-2.
4
Development and validation of a machine learning model for differential diagnosis of malignant pleural effusion using routine laboratory data.基于常规实验室数据的机器学习模型对恶性胸腔积液进行鉴别诊断的建立与验证。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231208632. doi: 10.1177/17534666231208632.
5
The Diagnosis of Malignant Pleural Effusion Using Tumor-Marker Combinations: A Cost-Effectiveness Analysis Based on a Stacking Model.使用肿瘤标志物组合诊断恶性胸腔积液:基于堆叠模型的成本效益分析
Diagnostics (Basel). 2023 Oct 5;13(19):3136. doi: 10.3390/diagnostics13193136.